What Causes Increased Vascularity in the Thyroid?

Increased vascularity in the thyroid is driven primarily by thyroid-stimulating hormone (TSH) and the angiogenic signaling molecules it triggers, especially vascular endothelial growth factor (VEGF). When TSH levels rise or when antibodies mimic TSH’s effects, thyroid cells ramp up production of growth factors that coax nearby blood vessels to expand and proliferate. The result is a gland that, on ultrasound, lights up with color Doppler signal, sometimes dramatically so. But the specific cause behind that increased blood flow matters enormously, because it can point to anything from Graves’ disease to pregnancy to certain thyroid cancers, and the clinical approach differs in each case.

How TSH Drives New Blood Vessel Growth

The thyroid gland is already one of the most richly supplied organs in the body relative to its size, but its vascularity is not fixed. TSH, the pituitary hormone that tells the thyroid to produce hormones, also tells thyroid cells to secrete VEGF and a related molecule called placental growth factor (PlGF). In animal and cell-culture studies, rising TSH levels led to increased production of these growth factors and their receptors on nearby blood-vessel cells. The conditioned medium from TSH-stimulated thyroid cells was enough to make endothelial cells proliferate, confirming a paracrine loop: thyroid cells talk to blood-vessel cells, telling them to grow.¹

In thyroid cancer cell lines, TSH boosted VEGF messenger RNA and protein by up to 40%. The signal traveled through a specific molecular pathway involving protein kinase C (PKC) rather than the more commonly discussed protein kinase A route. Blocking PKC cut VEGF production by up to 65%, while blocking PKA had only a minor effect.² This matters because it means the blood-vessel-building signal from TSH is partly independent of the hormone-production signal. In other words, the thyroid can be ramping up its blood supply even through pathways that are separate from its core job of making thyroid hormones.

Another player in thyroid angiogenesis is hypoxia-inducible factor 1-alpha (HIF-1α), which is best known for kicking in when tissues are starved of oxygen. In thyroid cancer cells, HIF-1α expression was markedly elevated, and knocking it down reduced levels of VEGF and its receptor VEGFR2.³ So rapidly growing thyroid tissue, whether benign or malignant, can outstrip its blood supply, become relatively oxygen-deprived, and trigger additional angiogenic signaling through HIF-1α on top of the TSH-driven pathway.

Graves’ Disease and the “Thyroid Inferno”

The most dramatic example of increased thyroid vascularity is Graves’ disease. In this autoimmune condition, antibodies bind to the TSH receptor and continuously stimulate the gland as if TSH itself were elevated. The thyroid responds by overproducing hormones and, through the mechanisms described above, flooding itself with new blood vessels. On color Doppler ultrasound, the gland lights up so intensely that radiologists coined the term “thyroid inferno” to describe the appearance.

Blood flow velocity in the thyroid arteries tells a quantitative story. Peak systolic velocity in the superior thyroid artery above about 54 cm/s had roughly 83% sensitivity and 86% specificity for identifying Graves’ disease, and values above about 85 cm/s were virtually diagnostic.⁴ The inferior thyroid arteries similarly show significantly higher peak systolic velocities in Graves’ disease compared to other causes of thyrotoxicosis, with color-flow Doppler reaching about 89% sensitivity and 88% specificity for distinguishing Graves’ from thyroiditis.⁵

The clinical relevance here is practical. When someone presents with thyrotoxicosis, the most common question is whether the excess thyroid hormone comes from a gland in overdrive (Graves’) or a gland that is injured and leaking stored hormone (thyroiditis). The treatment is completely different. High vascularity points strongly toward Graves’, while low or absent vascularity points toward a destructive process. Systemic vascular effects track alongside: in people with hyperthyroidism, baseline forearm blood flow was roughly three times higher than in controls, and this normalized once they were treated back to a normal thyroid state.⁶

Hashimoto’s Thyroiditis

Graves’ disease gets most of the attention for thyroid hypervascularity, but Hashimoto’s thyroiditis, the most common autoimmune thyroid condition, also increases blood flow to the gland, though for somewhat different reasons. In Hashimoto’s, the immune system infiltrates the thyroid with inflammatory cells. This chronic inflammation triggers local angiogenesis as part of the tissue’s response, and as the gland progressively loses function and TSH levels climb, the TSH-VEGF pathway adds to the effect.

Advanced imaging confirms how pronounced this can be. In a prospective study comparing Hashimoto’s patients to healthy controls using superb microvascular imaging, the vascularity index in both thyroid lobes was more than double in the Hashimoto’s group compared to controls. Among Hashimoto’s patients who had become hypothyroid, the vascularity index was roughly twice that of Hashimoto’s patients who still had normal thyroid function, consistent with elevated TSH driving additional blood vessel growth.⁷

Distinguishing Hashimoto’s from Graves’ on Doppler can matter when both conditions present with increased blood flow. A left inferior thyroid artery peak systolic velocity above about 26 cm/s was highly specific for autoimmune thyroid disease in general, but a threshold above about 62 cm/s helped separate Hashimoto’s from Graves’, with roughly 83% sensitivity and 87% specificity.⁸ In practice, the clinical picture usually makes the distinction clear, but in ambiguous cases these velocity measurements are genuinely useful.

When Vascularity Drops Instead of Rising

Not every form of thyroiditis increases blood flow, and the contrast is diagnostically valuable. In subacute thyroiditis, which is typically triggered by a viral infection, the thyroid becomes swollen and painful. But on color Doppler, the gland shows low echogenicity without increased tissue vascularity, which is the opposite of the pattern in Graves’ disease.⁹ The reason is straightforward: in subacute thyroiditis, the elevated thyroid hormones in the blood come from damaged follicular cells dumping their stored contents, not from a hyperactive gland building new vasculature. TSH is suppressed, so there is no angiogenic stimulus.

This same principle shows up in the two types of amiodarone-induced thyrotoxicosis. Amiodarone, a heart-rhythm drug that contains large amounts of iodine, can cause thyroid dysfunction in two distinct ways. Type I results from iodine-driven overproduction of thyroid hormones in a gland that already had some underlying abnormality, and it shows increased Doppler signal ranging from patchy to markedly diffuse. Type II results from direct toxic damage to thyroid cells, causing them to leak stored hormones, and it shows absent vascularity on color-flow Doppler. In one study, all type II patients had a pattern of no detectable parenchymal blood flow, while type I patients showed patterns consistent with a hyperfunctioning gland.¹⁰ Because the treatment is completely different for each type, this quick imaging distinction has real consequences for patient care.

Thyroid Vascularity During Pregnancy

Pregnancy is a physiological state that predictably increases thyroid vascularity, and it has nothing to do with disease. The thyroid gland works harder during pregnancy to meet the increased metabolic demands of both the mother and the developing fetus. Human chorionic gonadotropin (hCG), the hormone that rises sharply in early pregnancy, structurally resembles TSH and weakly stimulates the TSH receptor, pushing the gland to grow and increase its blood supply.

A study using superb microvascular imaging tracked thyroid vascularity across trimesters and found a significant stepwise increase. Vascularity index values in the third trimester were significantly higher than in both the first and second trimesters, and second-trimester values were significantly higher than first-trimester values. The thyroid gland volume and TSH levels also rose in parallel.¹¹ This progressive increase is normal and expected, but it can occasionally complicate imaging interpretation if a pregnant person undergoes thyroid ultrasound for other reasons, since the baseline vascularity is already elevated.

Autonomously Functioning Nodules

While diffuse hypervascularity typically points to conditions affecting the entire gland, focal increases in blood flow can arise from autonomously functioning thyroid nodules. These are nodules that produce thyroid hormones on their own, independent of TSH regulation, because they carry activating mutations in the TSH receptor gene or in genes that affect its downstream signaling.¹² Because the mutated receptor is constitutively “on,” the nodule behaves as though it is being constantly stimulated by TSH, driving local VEGF production and angiogenesis within and around the nodule itself.

On nuclear medicine scans, these show up as “hot” nodules that take up more radioactive tracer than surrounding tissue. On Doppler ultrasound, they tend to show increased peripheral and sometimes intranodular blood flow. When large enough to produce excess thyroid hormones and suppress TSH, the surrounding normal thyroid tissue actually becomes less vascular, since the low TSH removes the angiogenic stimulus from the non-autonomous tissue.

Thyroid Cancer and Blood Vessel Density

The relationship between vascularity and thyroid cancer is more nuanced than many people assume. There is a widespread belief that a highly vascular thyroid nodule is more likely to be cancerous, but the evidence is mixed. In one study evaluating color Doppler patterns for risk stratification, nodule vascularity on its own was not associated with a higher risk of malignant cytology, regardless of whether the blood flow was peripheral or within the nodule.¹³ This is why most current risk-stratification guidelines rely more heavily on features like irregular margins, microcalcifications, and a taller-than-wide shape rather than vascularity alone when deciding which nodules need biopsy.

Where vascularity does become relevant in thyroid cancer is at the tissue level, after surgery. High expression of CD31, a marker of blood vessel density in tumor tissue, has been associated with more advanced tumor stage, lymph node metastasis, extrathyroidal extension, and recurrence in papillary thyroid cancer.¹⁴ Similarly, microvessel density and microvessel area in surgical specimens have been identified as risk factors for lymph node metastasis in papillary thyroid cancer, and contrast-enhanced ultrasound features correlated with these tissue-level vascular markers.¹⁵

So the picture is this: simply seeing blood flow in or around a thyroid nodule on a standard Doppler ultrasound does not reliably predict whether it is benign or malignant. But once a cancer is confirmed, the degree to which it has built its own blood supply does carry prognostic weight. Tumors that have recruited dense networks of blood vessels tend to behave more aggressively.

Pediatric and Congenital Causes

Children can also present with increased thyroid vascularity, and one under-recognized cause is thyroid dyshormonogenesis, a group of inherited defects in the enzymes or transport proteins needed to synthesize thyroid hormones. Because the gland cannot efficiently make its products, TSH remains chronically elevated from birth, relentlessly driving gland growth and blood vessel proliferation. In a study of children with dyshormonogenesis, median vascularity index values were significantly higher than in controls, and those values correlated with thyroid gland volume, medication dose, and radioactive iodine uptake.¹⁶ In other words, the more severely the gland struggled to produce hormones, the higher the TSH, the larger the gland, and the more vascular it became.

Pediatric Graves’ disease, though less common than in adults, produces the same pattern of diffuse hypervascularity. The distinction from dyshormonogenesis is usually obvious on labs, since Graves’ causes hyperthyroidism (low TSH, high thyroid hormones) while dyshormonogenesis causes hypothyroidism (high TSH, low thyroid hormones). But on ultrasound, both can show impressively increased blood flow, which can be confusing if the clinical context is not clear to the sonographer.

How Thyroid Blood Flow Guides Treatment Decisions

Vascularity is not just a diagnostic curiosity; it directly influences treatment. In Graves’ disease, the degree of thyroid blood flow before starting anti-thyroid medication predicts how much drug will be needed. A study found that pre-treatment inferior thyroid artery velocity was significantly and positively associated with the maintenance dose of methimazole required to keep patients stable for at least a year.¹⁷ Higher blood flow at baseline meant the gland was more intensely active and needed more aggressive suppression.

Before thyroid surgery for Graves’ disease, surgeons have long used Lugol’s iodine (a potassium iodide solution) to reduce the gland’s vascularity and make the operation safer. The mechanism involves the Wolff-Chaikoff effect, in which a sudden flood of iodine temporarily shuts down thyroid hormone synthesis and, with it, the gland’s metabolic overdrive. Studies have confirmed that thallium uptake and circulating thyroid hormone levels fall significantly after iodine treatment, supporting the idea that blood flow to the gland genuinely decreases.¹⁸ A less engorged gland bleeds less during surgery, which is especially important given the delicate structures surrounding the thyroid, including the recurrent laryngeal nerves and the parathyroid glands.

Common Misconceptions About Thyroid Vascularity

One of the most persistent misunderstandings is that increased thyroid vascularity automatically means thyroid cancer. As discussed, standard Doppler vascularity of a thyroid nodule is a poor standalone predictor of malignancy. The features that raise concern for cancer on ultrasound are largely about the nodule’s shape, echogenicity, margins, and calcifications, not its blood flow pattern. Patients who are told their thyroid ultrasound shows “increased vascularity” are often alarmed, but the finding in isolation more commonly reflects autoimmune thyroid disease or a physiological state like pregnancy than it does cancer.

Another misconception is that increased vascularity always reflects hyperthyroidism. As the Hashimoto’s and dyshormonogenesis data show, some of the most vascular thyroids belong to people who are hypothyroid. Their TSH is high precisely because the gland is failing, and that elevated TSH keeps pushing angiogenesis even as the gland’s hormone output declines. The vascularity is a compensatory response, not a sign of overproduction.

A third point of confusion involves iodine deficiency. In populations with chronically low iodine intake, goiters develop partly because TSH stays elevated in an attempt to squeeze more hormone production out of an iodine-starved gland. The resulting chronic TSH stimulation drives the same VEGF-mediated angiogenesis seen in other high-TSH states, contributing to the enlarged, hypervascular goiters that are common in iodine-deficient regions. Iodine supplementation programs address the root cause and, over time, allow TSH to normalize and the excessive vascularity to recede.

Newer Imaging Technologies and What They Reveal

Traditional color Doppler ultrasound shows the presence or absence of blood flow and gives a rough sense of its intensity, but newer techniques are adding layers of detail. Superb microvascular imaging (SMI) can detect very slow, low-volume flow in tiny vessels that conventional Doppler misses entirely. This technology is what allowed researchers to quantify the vascularity differences in Hashimoto’s patients at such fine resolution, detecting a doubling of vascularity index even in patients whose conventional ultrasound might have looked unremarkable.⁷

Contrast-enhanced ultrasound, which uses injected microbubbles to trace blood flow in real time, is being explored for characterizing thyroid nodules and predicting cancer aggressiveness. It captures parameters like rise time, peak intensity, and area under the time-intensity curve that reflect the microvascular architecture of a nodule in ways that standard Doppler cannot. These contrast-enhanced features have shown correlations with microvessel density and lymph node metastasis risk in papillary thyroid cancer.¹⁵ Dual-energy CT is another emerging modality, combining anatomic detail with iodine-mapping capabilities that can reflect tissue-level vascularity and potentially help stratify recurrence risk in thyroid cancer patients who have already had surgery.¹⁴ These tools are still working their way into routine clinical use, but they point toward a future where thyroid vascularity assessment moves well beyond the binary “increased or not” question and into something meaningfully prognostic.

1
Nature. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization
2
Oxford Academic. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors
3
Europe PMC. Silencing of hypoxia-inducible factor-1α promotes thyroid cancer cell apoptosis and inhibits invasion by downregulating WWP2, WWP9, VEGF and VEGFR2
4
PubMed Central. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves’ Disease from Thyroiditis
5
Europe PMC. Role of color Doppler in differentiation of Graves’ disease and thyroiditis in thyrotoxicosis
6
Circulation. Impact of hyperthyroidism and its correction on vascular reactivity in humans
7
Galenos Publishing House / Diagnostic and Interventional Radiology. Vascularity assessment in Hashimoto’s thyroiditis: a prospective comparative study with power Doppler and superb microvascular imaging
8
PubMed Central. Value of the left inferior thyroid artery peak systolic velocity in diagnosing autoimmune thyroid disease
9
PubMed Central. Color Doppler ultrasonography in patients with subacute thyroiditis
10
PubMed Central. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis
11
PubMed Central / Elsevier. Evaluation of the thyroid gland vascularity during pregnancy using 2-dimensional color Superb Microvascular İmaging vascularization index technique
12
Bioscientifica / Endocrinol Diabetes Metab Case Rep. Locally invasive classical papillary thyroid carcinoma with TSH receptor I568T mutation: case report
13
European Thyroid Journal. Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules
14
PubMed Central. CD31-associated vascular phenotyping using Doppler ultrasound and dual-energy CT for recurrence risk stratification in papillary thyroid cancer
15
IOS Press / Clin Hemorheol Microcirc. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma
16
Elsevier / Ultrasound in Medicine & Biology. Multi-parametric Ultrasound Evaluation of Pediatric Thyroid Dyshormonogenesis
17
Elsevier. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves’ disease
18
PubMed Central. Lugol’s iodine: its effect on thyroid blood flow in patients with thyrotoxicosis